Multisorb Commences Manufacturing Operations in Hyderabad, India

Hyderabad, November 18, 2018: Multisorb, the leading provider of oxygen and moisture management technologies, today announced the inauguration of a new manufacturing facility in Hyderabad, India. This facility will be capable of producing Multisorb’s MiniPax®, StripPax®, IntelliSorb® and StabilOx® active packaging components, all industry-leading solutions for providing chemical and physical stability in pharmaceuticals and medical devices.

This new facility has completed validation and will begin production and delivery of Multisorb’s sorbent products in the coming weeks. The location was strategically selected to serve India’s growing Pharmaceutical sector, allowing Multisorb to better serve its India-based customers by dramatically shortening order-fulfillment lead time.

“Ultimately this leads to a more nimble relationship between Multisorb and its India-based customers. Our new location also provides the additional capacity necessary to accommodate growth at the pace of our customers’ needs,” said Eric Armenat, President and Chief Executive Officer, Multisorb.

Multisorb’s Hyderabad facility is ISO 9001:2015 certified and is held to the same high-quality standards and procedures deployed in the company’s U.S. production facilities. 

“Companies in India have played a significant role in global pharmaceutical manufacturing for many years,” advised Laxmikant Khaitan, General Manager, Multisorb. “We are very excited for the opportunity to build stronger relationships with the local community and customer base.”

Multisorb is a business of Filtration Group, the global leader in advanced filtration solutions across life science and industrial applications. With more than 100 locations globally and nearly two dozen locations in Asia-Pacific, Filtration Group is poised for additional growth in these key markets—both by bringing manufacturing operations and innovation centers closer to its customers and by leveraging new opportunities as these markets expand.

“We have invested in this world class facility to be closer to our customers and to continue to exceed their expectations in quality of product and service” said Jon Peacock, President of Filtration Group’s Life Sciences division.

Corporate Comm India(CCI NewsWire)